维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

17篇 您的检索式：作者名="Callander N S"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	A randomized trial of lenalidomide plus high-dose dexamethasone (RD) versus lenalidomide plus low-dose dexamethasone (Rd) in newly diagnosed multiple myeloma (EdA03): a trial coordinated by the Eastern Cooperative Oncology Group 显示文摘	Rajkumar SV Jacobus S Callander N	2007	Blood2007，110，：	1
	2	AML - 1A and AML - 1B regulation of MIP - 1 alpha expression in multiple myeloma显示文摘	CHOI S J OBA T CALLANDER N S	2003	Blood2003，101，10：	1
	3	Poiyphenols Inhihit Hepatitis C Virus Entry hy a New Mechanism of Action 显示文摘	CALLAND N SAHUC M E BELOUZARD S	2015	Journal of Virolggy2015，89，19：	1
	4	Severe,late-onset graft-versus-host disease in a liver transplant recipient documented by chimerism analysis显示文摘	POLLACK M S SPEEG K V CALLANDER N S	2005	Human Immunology2005，66，1：	1
	5	A randomized phase III trial of lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone in newly diagnosed multiple myeloma: a trial coordinated by the Eastern Cooperative Ontology Group显示文摘	Rajkumar SV Jacobus S Callander N	2006	Blood2006，108，4：	1
	6	Bortezomibresistant nuclear factor-kappaB activity in multiple myeloma cells显示文摘	Markovina S Callander N S O'Connor S L	2008	Mol Cancer Res2008，6，8：	1
	7	Outcome of elderly patients 70 years and older with newly diagnosed myeloma in the ECOG randomized trial of lenalidomide/high-dose dexa- methasone ( RD ) versus lenalidomide/low-dose dexamethasone (Rd) 显示文摘	Jacobus S Callander N Siegel D	2010	Haematologica2010，95，2：	1
	8	Immunohistochemical identification of tissue factor in solid tumors显示文摘	CALLANDER NS VARKI N RAOL V	1992	Cancer1992，70，5：	1
	9	( ) Epigallo catechin-3-gallate is a new inhibitor of hepatitis C virus entry显示文摘	Calland N Albecka A Belouzard S	2012	Hepatology2012，55，3：	1
	10	Lenalidomide plus highdose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma:an open-label randomized controlled trial显示文摘	Rajkumar SV Jacobus S Callander N	2010	Lancet Oncol2010，11，：	1
	11	Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma:an open-label randomized controlled trial显示文摘	Rajkumar SV Jacobus S Callander N	2010	Lancet Oncol2010，11，1：	1
	12	Acetyl-L-carnitine(ALCAR) for the prevention of chemotherapy-induced periph-eral neuropathy in patients with relapsed or refractory multiplemyeloma treated with bortezomib,doxorubicin and low-dosedexamethasone : a study from the Wisconsin Oncology Network显示文摘	Callander N Markovina S Eickhoff J	2014	Cancer Chemother Pharmacol2014，74，4：	1
	13	Immunohistochemical identification of tissue factor in solid tumors显示文摘	Callander N S Varki N Rao L	1992	Cancer1992，70，5：	1
	14	Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma显示文摘	RAJKUMAR S V JACOBUS S CALLANDER N S	2010	Lancet Oncol2010，11，：	1
	15	(-)-Epigallocatechin-3-Gallate Is a New Inhibitor of Hepatitis C Virus Entry Hepatology显示文摘	Calland N Albecka A Belouzard S Wychowski C Duverlie G Descamps V Hober D Dubuisson J RouilléY Séron K	2012	55(3):720-7292012，55，3：	1
	16	(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry显示文摘	Calland N Albecka A Belouzard S		0，，03：	1
	17	A randomized trial of lenalidomide plus high - dose dexamethasone (RD) versus lenalidomide plus low - dose dexamethasone (Rd) in newly diag-nosed multiple myeloma (E4A03): a trial coordinated by the Eastern Cooperative Oncology Group 显示文摘	Rajkumar SV Jacobus S Callander N	2007	Blood2007，110，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费